CAS: 1442472-39-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ripretinib REF: IN-DA01EO7KCAS: 1442472-39-0 | 98% | To inquire | Wed 04 Dec 24 |
 | Ripretinib REF: TM-T8482CAS: 1442472-39-0 | 99.72% | 198.00 €~5,402.00 € | Wed 11 Dec 24 |
 | Ripretinib REF: TR-R295060CAS: 1442472-39-0 | - - - | 15,186.00 € | Tue 14 Jan 25 |
 | Ripretinib (DCC-2618) REF: 3D-SHC47239CAS: 1442472-39-0 | Min. 95% | 185.00 €~1,563.00 € | Wed 15 Jan 25 |
Ripretinib
CAS:1442472-39-0
Formula:
C24H21BrFN5O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
510.3582
Ref: IN-DA01EO7K
| 2mg | 77.00 € | ||
| 5mg | 122.00 € | ||
| 10mg | 151.00 € | ||
| 25mg | 298.00 € | ||
| 50mg | 476.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Ripretinib
CAS:1442472-39-0
Ripretinib (DCC-2618) is an orally bioavailable inhibitor of KIT and PDGFRA.
Formula:
C24H21BrFN5O2
Purity:
99.72%
Color and Shape:
Solid
Molecular weight:
510.36
- Inhibitors
- Apoptosis
- VEGFR
- PDGFR
- See more categories
- c-Kit
Ref: TM-T8482
| 1mg | 391.00 € | ||
| 2mg | 585.00 € | ||
| 5mg | 930.00 € | ||
| 10mg | 1,274.00 € | ||
| 25mg | 1,722.00 € | ||
| 50mg | 2,401.00 € | ||
| 100mg | 3,353.00 € | ||
| 500mg | 5,402.00 € | ||
| 1mL*10mM (DMSO) | 427.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ripretinib
Controlled ProductCAS:1442472-39-0
Formula:
C24H21BrFN5O2
Color and Shape:
Neat
Molecular weight:
510.358
Ref: TR-R295060
| 75mg | 15,186.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ripretinib (DCC-2618)
CAS:1442472-39-0
Ripretinib is a potent, orally bioavailable inhibitor of the tyrosine kinase activity of RET. It …
Formula:
C24H21BrFN5O2
Purity:
Min. 95%
Molecular weight:
510.36 g/mol
Ref: 3D-SHC47239
| 5mg | 392.00 € | ||
| 50mg | 1,563.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
